Zhang Jie, Hu Dawei
Department of Breast Surgery, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, People's Republic of China.
Cancer Manag Res. 2021 Jan 11;13:133-145. doi: 10.2147/CMAR.S279121. eCollection 2021.
Breast cancer (BC) has deleterious effects on women's health worldwide, yet its molecular mechanism remains unclear.
This study aimed to discover the underlying mechanism used by miR-1298-5p to regulate in BC.
Microarray analysis was performed to identify the key mRNA and miRNA involved in BC. The expression of miR-1298-5p and mRNA in BC clinical tissues and cell lines was detected using quantitative reverse transcription PCR (RT-qPCR), while the demonstration of intra- and extra-cellular protein was measured using western-blotting or ELISA assay. CCK-8, BrdU ELISA, colony formation, wound healing, and cell adhesion assays were carried out to determine cell viability, cell proliferation, colony formation, cell migration and adhesion phenotypes, respectively. A dual-luciferase assay kit was also employed to confirm the predicted binding scheme between miR-1298-5p and .
Microarray analysis confirmed miR-1298-5p and as the miRNA and mRNA to be further investigated in BC. After observing low-level miR-1298-5p and high-level in BC clinical tissues and cell lines, it was discovered that miR-1298-5p inhibited the phenotypes of BC cells, while promoted the tumorigenesis of BC cells. Findings indicated that miR-1298-5p attenuated the promotive effect of on BC cell phenotypes.
This research revealed that miR-1298-5p could influence the malignancy phenotypes of BC cells by inhibiting .
乳腺癌(BC)对全球女性健康具有有害影响,但其分子机制仍不清楚。
本研究旨在发现miR-1298-5p在乳腺癌中用于调节的潜在机制。
进行微阵列分析以鉴定参与乳腺癌的关键mRNA和miRNA。使用定量逆转录PCR(RT-qPCR)检测乳腺癌临床组织和细胞系中miR-1298-5p和mRNA的表达,同时使用蛋白质印迹或ELISA测定法测量细胞内和细胞外蛋白的表达。分别进行CCK-8、BrdU ELISA、集落形成、伤口愈合和细胞粘附试验以确定细胞活力、细胞增殖、集落形成、细胞迁移和粘附表型。还使用双荧光素酶测定试剂盒来确认miR-1298-5p与之间预测的结合模式。
微阵列分析证实miR-1298-5p和为在乳腺癌中有待进一步研究的miRNA和mRNA。在观察到乳腺癌临床组织和细胞系中miR-1298-5p水平低而水平高之后,发现miR-1298-5p抑制乳腺癌细胞的表型,而促进乳腺癌细胞的肿瘤发生。研究结果表明,miR-1298-5p减弱了对乳腺癌细胞表型的促进作用。
本研究表明,miR-1298-5p可通过抑制来影响乳腺癌细胞的恶性表型。